Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00452075
Status:
TERMINATED
Last Update Posted:
2014-12-11
First Post:
2007-03-23
Brief Title:
Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer NSCLC for Patients Unfit for Chemotherapy
Sponsor:
Rigshospitalet Denmark
Organization:
Rigshospitalet Denmark
Organization Data
Organization:
Rigshospitalet Denmark
Class:
OTHER
Study ID:
ML 20539
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rigshospitalet Denmark
Lead Sponsor Class:
OTHER
Responsible Party:
Gedske Daugaard
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Rigshospitalet Denmark
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |